Balentine LLC’s Zai Lab ZLAB Stock Holding History

Balentine LLC’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-22	Closed	-$2K	–	868
2020 Q2	$2K	Buy	+22	New	+$1.49K	﹤0.01%	873

Other funds holding ZLAB

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

ZAM

Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Balentine LLC's ZLAB Position: Q3 2020 in Review

Balentine LLC sold out of Zai Lab (ZLAB) in Q3 2020, closing a stake of 22 shares — an estimated $2K sold.

Balentine LLC first reported a position in ZLAB in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 176 funds tracked by Wall St. Rank hold ZLAB as of Q3 2020.

Balentine LLC reported no remaining Zai Lab position as of Q3 2020 after selling out during the quarter.
Balentine LLC sold 22 Zai Lab shares in Q3 2020, an estimated $2K.
Balentine LLC first reported a position in Zai Lab in Q2 2020 and held it in 1 quarter.
Balentine LLC's Zai Lab position peaked at $2K in Q2 2020.
176 funds tracked by Wall St. Rank held Zai Lab as of Q3 2020.

Based on Balentine LLC's 13F filing for Q3 2020, filed 2 Nov 2020.